Sialorrhoea is a frequent symptom of neurological diseases (eg Parkinson's disease, motor
neuron disease, cerebral palsy, and stroke) and is defined as excessive saliva accumulation …

In the past 4 years, two adjunctive treatment options to levodopa have been licensed for use
in the UK in patients with Parkinson's disease (PD) and motor fluctuations: opicapone, a …

Background To develop an effective, patient-centred and sustainable service, we set up a
virtual clinic (VC) for patients with Parkinson's disease, combining phone consultations and …

In the UK, guidance exists to aid clinicians and patients deciding when treatment for
Parkinson's disease (PD) should be initiated and which therapies to consider. National …

Objectives To examine the use of cognitive behavioral therapy (CBT) in a case of co-
occurring generalized anxiety disorder (GAD) and Parkinson's disease (PD). Methods This …

Aims: To carry out a cost-utility analysis comparing the cost-effectiveness of levodopa
carbidopa intestinal gel (LCIG) with standard of care (SOC) in patients with advanced …

Introduction A timely diagnosis of dementia is crucial for initiating and maintaining support
for people living with dementia. The coronavirus disease (COVID) pandemic temporarily …

Anticholinergic agents are used in a number of conditions ranging from overactive bladder
and bradycardia to travel sickness but side‐effects such as hallucinations, impaired memory …

Background People with Parkinson′ s disease (PD) have an increased risk of dementia,
yet patients and clinicians frequently avoid talking about it due to associated stigma, and the …

The use of accelerometer device technology in Parkinson's disease allows a period of
continuous monitoring giving insight into disease pattern and aiding the optimisation of …